At the June 5-6, 2023 meeting, the Board approved PCORI investing up to $600 million in patient-centered comparative clinical effectiveness research (CER) through the development of funding opportunities for eight intersectional Topic Themes that address health issues spanning chronic conditions to emerging needs. Read more about this approved item here.

The Board also received the Executive Director's report and engaged in a strategy discussion about advancing PCORI's CER portfolio, among other business. View the agenda for details.

Meeting Materials

Webinar Recordings

Approved Minutes of the June 5 & 6, 2023 Board Meeting

Public Comment Period

This meeting included a public comment period. Registration# was required to provide comments via telephone. (Guidelines for Public Comments) (Technical Guidance for Commenters). However, there were no confirmed requests to provide comments by 5pm ET on the business day before the scheduled public comment period, so the public comment period was not initiated.

All PCORI Board meetings are open to the public. Members of the public were invited to join this meeting, which took place in Washington, DC, via teleconference/webinar. Registration was required.

Catch up on past PCORI Board meetings here.

*This agenda was subject to change. The meeting adjourned at 3:15 p.m. (ET).

^This presentation slide deck covers June 5 and June 6. Slides for June 6 begin at page 49.

#Please note that after you sign up to provide comment at this meeting, you will receive a confirmation email from PCORI about your registration. Please check your spam folder for this email if you don’t receive it, and reply to the email to confirm your intention to make a public comment.


Location Type